INTRODUCTION: Changes to the tumour bed following oncoplastic breast surgery complicate the administration of adjuvant radiotherapy. Consensus guidelines have called for improved interdisciplinary communication to aid adjuvant boost radiotherapy. We propose a framework of tumour bed classification following oncoplastic surgery to enhance understanding and communication between the multidisciplinary breast cancer team and facilitate effective and more precise delivery of adjuvant boost radiotherapy. METHODS: A classification system was devised by grouping oncoplastic procedures based on skin incision, tissue mobilization, tumour bed distortion, seroma formation and flap reconstruction. The system is supplemented by a colour-coded pictorial guide to tumour bed rearrangement with common oncoplastic procedures. RESULTS: A 5-tier framework was developed. Representative images were produced to describe tumour bed alterations. CONCLUSION: The proposed framework (OPSURGE) improves the identification of the primary tumour bed after initial breast-conserving surgery, which is imperative to both the surgeon in planning re-excision and the radiation oncologist in planning boost radiotherapy.
Clough KB, Kaufman GJ, Nos C, Buccimazza I, Sarfati IM. Improving breast cancer surgery: a classification and quadrant per quadrant atlas for oncoplastic surgery. Ann. Surg. Oncol. 2010; 17: 1375–1391.
Metz G, Snook K, Sood S et al. Breast radiotherapy after oncoplastic surgery—a multidisciplinary approach. Cancers 2022; 14: 1685.
Char S, Bloom JA, Erlichman Z, Jonczyk M, Chatterjee A, Guo L. How does oncoplastic surgery compare with standard partial mastectomy? A systematic review of patient‐reported outcomes. Plast. Reconstr. Surg. 2022; 150: 950e–958e.
Citgez B, Yigit B, Bas S. Oncoplastic and reconstructive breast surgery: a comprehensive review. Cureus 2022; 14: e21763.
Clough KB, van la Parra RFD, Thygesen HH et al. Long‐term results after oncoplastic surgery for breast cancer: a 10‐year follow‐up. Ann. Surg. 2018; 268: 165–171.
De Lorenzi F, Loschi P, Bagnardi V et al. Oncoplastic breast‐conserving surgery for tumors larger than 2 centimeters: is it Oncologically safe? A matched‐cohort analysis. Ann. Surg. Oncol. 2016; 23: 1852–1859.
Crown A, Laskin R, Rocha FG, Grumley J. Extreme oncoplasty: expanding indications for breast conservation. Am. J. Surg. 2019; 217: 851–856.
Eaton BR, Losken A, Okwan‐Duodu D et al. Local recurrence patterns in breast cancer patients treated with oncoplastic reduction mammaplasty and radiotherapy. Ann. Surg. Oncol. 2014; 21: 93–99.
Coles CE, Wilson CB, Cumming J et al. Titanium clip placement to allow accurate tumour bed localisation following breast conserving surgery: audit on behalf of the IMPORT trial management group. Eur. J. Surg. Oncol. 2009; 35: 578–582.
Tse T, Knowles S, Bélec J et al. Consensus statement on tumour bed localization for radiation after oncoplastic breast surgery. Curr. Oncol. 2020; 27: e326–e331.
Boyages J. Radiation therapy and early breast cancer: current controversies. Med. J. Aust. 2017; 207: 216–222.
Zissiadis Y, Langlands AO, Barraclough B, Boyages J. Breast conservation: long‐term results from Westmead Hospital. Aust. N. Z. J. Surg. 1997; 67: 313–319.
van Dongen JA, Voogd AC, Fentiman IS et al. Long‐term results of a randomized trial comparing breast‐conserving therapy with mastectomy: European Organization for Research and Treatment of cancer 10801 trial. J. Natl. Cancer Inst. 2000; 92: 1143–1150.
Arvold ND, Taghian AG, Niemierko A et al. Age, breast cancer subtype approximation, and local recurrence after breast‐conserving therapy. J. Clin. Oncol. 2011; 29: 3885–3891.
van der Leij F, Elkhuizen PHM, Bartelink H, van de Vijver MJ. Predictive factors for local recurrence in breast cancer. Semin. Radiat. Oncol. 2012; 22: 100–107.
Doyle T, Schultz DJ, Peters C, Harris E, Solin LJ. Long‐term results of local recurrence after breast conservation treatment for invasive breast cancer. Int. J. Radiat. Oncol. Biol. Phys. 2001; 51: 74–80.
Bartelink H, Maingon P, Poortmans P et al. Whole‐breast irradiation with or without a boost for patients treated with breast‐conserving surgery for early breast cancer: 20‐year follow‐up of a randomised phase 3 trial. Lancet Oncol. 2015; 16: 47–56.
Graham P, Fourquet A. Placing the boost in breast‐conservation radiotherapy: a review of the role, indications and techniques for breast‐boost radiotherapy. Clin. Oncol. (R. Coll. Radiol.) 2006; 18: 210–219.
Van Parijs H, Miedema G, Vinh‐Hung V et al. Short course radiotherapy with simultaneous integrated boost for stage I‐II breast cancer, early toxicities of a randomized clinical trial. Radiat. Oncol. 2012; 1: 80.
Aldosary G, Caudrelier J‐M, Arnaout A et al. Can we rely on surgical clips placed during oncoplastic breast surgery to accurately delineate the tumor bed for targeted breast radiotherapy? Breast Cancer Res. Treat. 2021; 186: 343–352.
Wang WEI, French J, Boyages J. Put the felt pen away: time to move on from a clinical mark‐up for a breast boost. J. Med. Imaging Radiat. Oncol. 2012; 56: 375–378.
Boyages J, Baker L. Evolution of radiotherapy techniques in breast conservation treatment. Gland Surg. 2018; 7: 576–595.
Srivastava V, Basu S, Shukla VK. Seroma formation after breast cancer surgery: what we have learned in the last two decades. J. Breast Cancer 2012; 15: 373–380.
Zeidan B, Rainsbury D. Breast cancer surgery: short‐term complications and management. In: Rezai M, Kocdor MA, Canturk NZ (eds). Breast Cancer Essentials: Perspectives for Surgeons. Cham: Springer International Publishing, 2021; 539–556.
Arnaout A, Ross D, Khayat E et al. Position statement on defining and standardizing an oncoplastic approach to breast‐conserving surgery in Canada. Curr. Oncol. 2019; 26: e405–e409.
Royal College of Radiologists. Postoperative Radiotherapy for Breast Cancer: UK Consensus Statements; 2016.
Chatterjee A, Gass J, Patel K et al. A consensus definition and classification system of oncoplastic surgery developed by the american society of breast surgeons. Ann. Surg. Oncol. 2019; 26: 3436–3444.
Montazeri A. Health‐related quality of life in breast cancer patients: a bibliographic review of the literature from 1974 to 2007. J. Exp. Clin. Cancer Res. 2008; 27: 32.
Okamura M, Yamawaki S, Akechi T, Taniguchi K, Uchitomi Y. Psychiatric disorders following first breast cancer recurrence: prevalence, associated factors and relationship to quality of life. Jpn. J. Clin. Oncol. 2005; 35: 302–309.
Mahvi DA, Liu R, Grinstaff MW, Colson YL, Raut CP. Local cancer recurrence: the realities, challenges, and opportunities for new therapies. CA Cancer J. Clin. 2018; 68: 488–505.
Kindts I, Laenen A, Depuydt T, Weltens C. Tumour bed boost radiotherapy for women after breast‐conserving surgery. Cochrane Database Syst. Rev. 2017; 11: CD011987.
Bartelink H, Horiot J‐C, Poortmans PM et al. Impact of a higher radiation dose on local control and survival in breast‐conserving therapy of early breast cancer: 10‐year results of the randomized boost versus no boost EORTC 22881‐10882 trial. J. Clin. Oncol. 2007; 25: 3259–3265.
Pezner RD, Tan MC, Clancy SL, Chen Y‐J, Joseph T, Vora NL. Radiation therapy for breast cancer patients who undergo oncoplastic surgery: localization of the tumor bed for the local boost. Am. J. Clin. Oncol. 2013; 36: 535–539.
Chen J‐Y, Huang Y‐J, Zhang L‐L, Yang C‐Q, Wang K. Comparison of oncoplastic breast‐conserving surgery and breast‐conserving surgery alone: a meta‐analysis. J. Breast Cancer 2018; 21: 321–329.
Chagpar AB, Killelea BK, Tsangaris TN et al. A randomized, controlled trial of cavity shave margins in breast cancer. N. Engl. J. Med. 2015; 373: 503–510.
Smith BD, Bellon JR, Blitzblau R et al. Radiation therapy for the whole breast: executive summary of an American Society for Radiation Oncology (ASTRO) evidence‐based guideline. Pract. Radiat. Oncol. 2018; 8: 145–152.
Shaitelman SF, Anderson BM, Arthur DW et al. Partial breast irradiation for patients with early‐stage invasive breast cancer or ductal carcinoma in situ: an ASTRO clinical practice guideline. Pract. Radiat. Oncol. 2024; 14: 112–132.
Meattini I, Marrazzo L, Saieva C et al. Accelerated partial‐breast irradiation compared with whole‐breast irradiation for early breast cancer: long‐term results of the randomized phase III APBI‐IMRT‐Florence trial. J. Clin. Oncol. 2020; 38: 4175–4183.
Bonci EA, Anacleto JC, Cardoso MJ. Sometimes it is better to just make it simple. De‐escalation of oncoplastic and reconstructive procedures. Breast 2023; 69: 265–273.
Roth A‐M, Kauer‐Dorner D, Resch A et al. Is oncoplastic surgery a contraindication for accelerated partial breast radiation using the interstitial multicatheter brachytherapy method? Brachytherapy 2014; 13: 394–399.
Ebner F, de Gregorio N, Rempen A et al. To clip or not to clip the breast tumor bed? A retrospective look at the geographic miss index and normal tissue index of 110 patients with breast cancer. J Turk Ger Gynecol Assoc. 2017; 18: 67–71.
Kirwan CC, Al Sarakbi W, Loncaster J, Chan HY, Thompson AM, Wishart GC. Tumour bed clip localisation for targeted breast radiotherapy: compliance is proportional to trial‐related research activity: tumour bed clip localisation in breast radiotherapy. Eur. J. Surg. Oncol. 2014; 40: 158–162.
Mitchell S, Lee H, DuPree BB et al. A novel, adaptable, radiographically opaque, multi‐plane continuous filament marker for optimizing tissue identification, radiation planning, and radiographic follow‐up. Gland Surg. 2019; 8: 609–617.
Lamb BW, Green JSA, Benn J, Brown KF, Vincent CA, Sevdalis N. Improving decision making in multidisciplinary tumor boards: prospective longitudinal evaluation of a multicomponent intervention for 1,421 patients. J. Am. Coll. Surg. 2013; 217: 412–420.
Blackwood O, Deb R. Multidisciplinary team approach in breast cancer care: benefits and challenges. Indian J. Pathol. Microbiol. 2020; 63: S105–S112.
Hoffmann J, Wallwiener D. Classifying breast cancer surgery: a novel, complexity‐based system for oncological, oncoplastic and reconstructive procedures, and proof of principle by analysis of 1225 operations in 1166 patients. BMC Cancer 2009; 8: 108.
La Padula S, Billon R, Schonauer F et al. Skin‐reducing oncoplasty: a new concept and classification in breast cancer surgery. Ann. Chir. Plast. Esthet. 2018; 63: 285–293.
Munhoz AM, Montag E, Arruda E et al. Assessment of immediate conservative breast surgery reconstruction: a classification system of defects revisited and an algorithm for selecting the appropriate technique. Plast. Reconstr. Surg. 2008; 121: 716–727.
Weber WP, Soysal SD, Fulco I et al. Standardization of oncoplastic breast conserving surgery. Eur. J. Surg. Oncol. 2017; 43: 1236–1243.
Garreffa E, Hughes‐Davies L, Russell S, Lightowlers S, Agrawal A. Definition of tumor bed boost in oncoplastic breast surgery: an understanding and approach. Clin. Breast Cancer 2020; 20: e510–e515.
Coles CE, Haviland JS, Kirby AM et al. Dose‐escalated simultaneous integrated boost radiotherapy in early breast cancer (IMPORT HIGH): a multicentre, phase 3, non‐inferiority, open‐label, randomised controlled trial. Lancet 2023; 401: 2124–2137.
Vicini FA, Winter K, Freedman GM. Phase III trial of hypo fractionated whole breast irradiation with concurrent boost vs. conventional whole breast irradiation plus sequential boost following lumpectomy. J. Radiat. 2022; 114: S1.
Forster T, Köhler C, Dorn M et al. Noninferiority of local control and comparable toxicity of intensity modulated radiation therapy with simultaneous integrated boost in breast cancer: 5‐year results of the IMRT‐MC2 phase III trial. Int. J. Radiat. Oncol. Biol. Phys. 2023; 117: 857–868.
Stroom J, Schlief A, Alderliesten T, Peterse H, Bartelink H, Gilhuijs K. Using histopathology breast cancer data to reduce clinical target volume margins at radiotherapy. Int. J. Radiat. Oncol. Biol. Phys. 2009; 74: 898–905.
Hanbeukers B, Borger J, van den Ende P et al. Customized computed tomography‐based boost volumes in breast‐conserving therapy: use of three‐dimensional histologic information for clinical target volume margins. Int. J. Radiat. Oncol. Biol. Phys. 2009; 75: 757–763.
Verhoeven K, Peeters S, Erven K et al. Boost delineation in breast radiation therapy: isotropic versus anisotropic margin expansion. Pract. Radiat. Oncol. 2016; 6: e243–e248.
Moghaddasi L, Bezak E, Marcu LG. Current challenges in clinical target volume definition: tumour margins and microscopic extensions. Acta Oncol. 2012; 51: 984–995.
Spillane AJ, Brennan ME. Minimal access breast surgery: a single breast incision for breast conservation surgery and sentinel lymph node biopsy. Eur. J. Surg. Oncol. 2009; 35: 380–386.
Lovasik BP, Seidel RL, Novello M, Torres MA, Losken A, Rizzo M. Single incision for oncologic breast conserving surgery and sentinel node biopsy in early stage breast cancer: a minimally invasive approach. Breast J. 2019; 25: 41–46.
Bartels SAL, Donker M, Poncet C et al. Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer: 10‐year results of the randomized controlled EORTC 10981‐22023 AMAROS trial. J. Clin. Oncol. 2023; 41: 2159–2165.
Correa C, Harris EE, Leonardi MC et al. Accelerated partial breast irradiation: executive summary for the update of an ASTRO evidence‐based consensus statement. Pract. Radiat. Oncol. 2017; 7: 73–79.
Young‐Afat DA, Gregorowitsch ML, van den Bongard DH et al. Breast edema following breast‐conserving surgery and radiotherapy: patient‐reported prevalence, determinants, and effect on health‐related quality of life. JNCI Cancer Spectr. 2019; 3: pkz011.
Juneja P, Bonora M, Haviland JS, Harris E, Evans P, Somaiah N. Does breast composition influence late adverse effects in breast radiotherapy? Breast 2016; 26: 25–30.
Mukesh MB, Barnett G, Cumming J et al. Association of breast tumour bed seroma with post‐operative complications and late normal tissue toxicity: results from the Cambridge breast IMRT trial. Eur. J. Surg. Oncol. 2012; 38: 918–924.